Literature DB >> 17514615

Surrogate end points in clinical trials: the case of anti-neutrophil cytoplasm antibody-associated vasculitis.

Michael Walsh1, Marcello Tonelli, David Jayne, Braden Manns.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17514615

Source DB:  PubMed          Journal:  J Nephrol        ISSN： 1121-8428            Impact factor:   3.902


× No keyword cloud information.
  1 in total

1.  Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial.

Authors:  Michael Walsh; Peter A Merkel; Chen Au Peh; Wladimir Szpirt; Loïc Guillevin; Charles D Pusey; Janak De Zoysa; Natalie Ives; William F Clark; Karen Quillen; Jeffrey L Winters; Keith Wheatley; David Jayne
Journal:  Trials       Date:  2013-03-14       Impact factor: 2.279
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.